Skip to main content
Have a personal or library account? Click to login
Formulation of stimuli-responsive gels containing silver complex with nicotinamide Cover

Formulation of stimuli-responsive gels containing silver complex with nicotinamide

Open Access
|Aug 2025

Figures & Tables

Table 1.

Composition of formulations.

FormulationPF127 (% w/w)MC (% w/w)SA (% w/w)AgNam (% w/w)
PMSA 0.215.000.250.20-
PMSA 0.315.000.250.30-
PMSA 0.415.000.250.40-
PMSA 0.515.000.250.50-
PMSA 0.615.000.250.60-
PMSA 0.715.000.250.70-
PMSA 0.815.000.250.80-
PSA15.00-4.00-
PMSA15.000.254.00-
MSA-0.254.00-
SA--4.00-
PMSA AgNam15.000.254.001.00
Table 2.

Appearance and injectability of sols and gels.

FormulationAppearanceInjectability (needle diameter)
SolGel0.5 mm0.6 mm0.7 mm0.8 mm
PMSA 0.2+++++++++++
PMSA 0.3++++++++++
PMSA 0.4++++++++++++
PMSA 0.5++++++++++++
PMSA 0.6+++++++++++
PMSA 0.7+++++++++
PMSA 0.8+++++++++
PSA+++++
PMSA+++++
MSA+++++
SA+++++
PMSA AgNam+++

[i] Appearance: (+) turbid – turbidity or suspended particles are present; (++) transparent – minimal turbidity or opalescence is present; (+++) glassy – without turbidity or opalescence; (−) no gelation.

[ii] Injectability: injectable, the sol exits dropwise (+), injectable, the sol exits dropwise almost forming a stream (++), injectable, the sol exits as a stream (+++), noninjectable (−)

Table 3.

pH and critical sol–gel transition temperature of the formulations.

FormulationpH ± SD (n = 3)Tsg (°C) ± SD (n=3)
PMSA 0.26.78 ± 0.00-
PMSA 0.36.72 ± 0.00-
PMSA 0.46.70 ± 0.0034.10 ± 0.28
PMSA 0.56.68 ± 0.0133.36 ± 0.13
PMSA 0.66.64 ± 0.0032.66 ± 0.17
PMSA 0.76.61 ± 0.0033.60 ± 0.08
PMSA 0.86.60 ± 0.0131.50 ± 0.36
PSA6.16 ± 0.02-
PMSA6.26 ± 0.00-
MSA5.84 ± 0.00-
SA5.75 ± 0.01-
PMSA AgNAM5.61± 0.02-
Figure 1.

Dissolution profile of methylene blue.

Figure 2.

Dissolution profile of PMSA AgNam.

Figure 3.

Antibacterial activity of PMSA AgNam. n = 3 ± SD. A, B, C represent statistically significant differences in the efficacy of tested samples. Values marked with the same letter are not significantly different from each other. Statistically significant differences are marked as follows: * for p < 0.05; ** for p < 0.01; *** for p < 0.001. The same significance applies for swab 1 and 2 for all pairs.

Figure 4.

Inhibition zones for Streptococcus pyogenes.

DOI: https://doi.org/10.2478/afpuc-2025-0007 | Journal eISSN: 2453-6725 (formerly 1338-6786) | Journal ISSN: 0301-2298
Language: English
Page range: 47 - 53
Submitted on: Jun 9, 2025
Accepted on: Jul 8, 2025
Published on: Aug 31, 2025
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Related subjects:

© 2025 Wolaschka Tomáš, Rohaľová Simona, Průšová Ivana, Hisirová Simona, Mudroňová Dagmar, Vargová Zuzana, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.